Anteverted nostril
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Mice lacking SLC25A46 displayed severe ataxia, mainly caused by degeneration of Purkinje cells.
|
28934388 |
2017 |
Bulbous nose
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar Ataxia
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
SLC25A46 Mutations Associated with Autosomal Recessive Cerebellar Ataxia in North African Families.
|
28558379 |
2017 |
Cerebellar Ataxia
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Mice lacking SLC25A46 displayed severe ataxia, mainly caused by degeneration of Purkinje cells.
|
28934388 |
2017 |
Cerebellar Dysmetria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Charcot-Marie-Tooth Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Charcot-Marie-Tooth Disease, Type Ia (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Charcot-Marie-Tooth Disease, Type Ib
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Congenital pontocerebellar hypoplasia
|
0.030 |
Biomarker
|
disease |
BEFREE |
This genotype-phenotype correlation underscores the importance of SLC25A46 and fine tuning of mitochondrial fission and fusion in pontocerebellar hypoplasia and central neurodevelopment in addition to optic and peripheral neuropathy across the life span.
|
27543974 |
2016 |
Congenital pontocerebellar hypoplasia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Our study adds to the definition of the SLC25A46-associated phenotypic spectrum that includes neonatal fatalities due to PCH as the severe extreme.
|
28653766 |
2018 |
Congenital pontocerebellar hypoplasia
|
0.030 |
Biomarker
|
disease |
BEFREE |
The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.
|
28376086 |
2017 |
Distal sensory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Exotropia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Flexion contracture
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait, Drop Foot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.
|
29656927 |
2018 |
Hereditary Motor and Sensory Neuropathy Type I
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Hereditary motor and sensory neuropathy with optic atrophy (disorder)
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Hereditary motor and sensory neuropathy with optic atrophy (disorder)
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Biallelic mutations in SLC25A46, encoding a modified solute transporter involved in mitochondrial dynamics, have been identified in a wide range of conditions such as hereditary motor and sensory neuropathy with optic atrophy type VIB (OMIM: *610826) and congenital lethal pontocerebellar hypoplasia (PCH).
|
28653766 |
2018 |
Hereditary motor and sensory neuropathy with optic atrophy (disorder)
|
0.510 |
Biomarker
|
disease |
MGD |
Novel insights into SLC25A46-related pathologies in a genetic mouse model.
|
28376086 |
2017 |
Hereditary Motor and Sensory-Neuropathy Type II
|
0.320 |
Biomarker
|
disease |
CTD_human |
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
|
26168012 |
2015 |
Hereditary Motor and Sensory-Neuropathy Type II
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SLC25A46 gene have been identified in mitochondrial diseases that are sometimes classified as Charcot-Marie-Tooth disease type 2, optic atrophy and Leigh syndrome.
|
29604258 |
2018 |